Staphylococcus colonization, mortality and morbidity in hemodialysis patients: 10 years of observation

被引:6
|
作者
Gruenewald, Thomas [1 ]
Lindner, Margareta [3 ]
Weiss, Susanne [2 ]
Ruf, Iris [2 ]
Treutler, Till [1 ]
Ruf, Bernhard [1 ]
Beige, Joachim [1 ,2 ]
机构
[1] Hosp St Georg, Dept Infect Dis & Nephrol, D-04129 Leipzig, Germany
[2] Hosp St Georg, Kuratorium Dialysis & Transplantat KfH Renal Unit, D-04129 Leipzig, Germany
[3] Hosp St Georg, Dept Lab Med & Microbiol, D-04129 Leipzig, Germany
关键词
Staphylococcus; MRSA; MSSA; Mortality; Catheter; Access; Dialysis; NASAL CARRIAGE; AUREUS; INFECTION; RISK; OUTCOMES;
D O I
10.1016/j.ijheh.2013.02.005
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Colonization with Staphylococci is widely distributed among patients with end-stage renal disease who are receiving hemodialysis (HD). In addition to more intensive care and use of artificial devices, the incidence of methicillin-resistant Staphylococcus aureus (MRSA) colonization and infection has increased. Such colonization has recently been associated with a more than doubled mortality rate in HD patients. However, it is not clear whether the (presumably increasing) incidence of methicillin-sensitive Staphylococcus aureus (MSSA) colonization is associated with MRSA and/or morbidity and mortality. We therefore established a screening program in our HD population (n=156) and followed these patients over 10 years. We discovered eighty-eight MSSA-colonized patients and one MRSA-colonized patient by cross-sectional and admission-related screenings between 2000 and 2010. The morbidity and mortality of the HD patients was not related to MSSA colonization. The MSSA colonization rate decreased slightly during the 10-year observation period. We conclude that the incidence of MRSA colonization in our unit was lower compared to that reported in the literature. The reasons for this finding are complex and require further investigation. The incidence of MSSA colonization was frequent but did not impact morbidity or mortality. (C) 2013 Elsevier GmbH. All rights reserved.
引用
收藏
页码:751 / 754
页数:4
相关论文
共 50 条
  • [1] MORBIDITY AND MORTALITY OF CENTRAL VENOUS CATHETER HEMODIALYSIS - A REVIEW OF 10 YEARS EXPERIENCE
    VANHOLDER, R
    HOENICH, N
    RINGOIR, S
    NEPHRON, 1987, 47 (04): : 274 - 279
  • [2] THE MORBIDITY AND THE MORTALITY IN CHRONIC HEMODIALYZED PATIENTS - THE 20 YEARS EXPERIENCE OF A HEMODIALYSIS CENTER
    URSEA, N
    MIRCESCU, G
    CAPSA, D
    VERZAN, C
    CONSTANTINOVICI, N
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 565 - 565
  • [3] Colonization with methicillin-resistant Staphylococcus aureus in ICU patients:: Morbidity, mortality, and glycopeptide use
    Garrouste-Orgeas, M
    Timsit, JF
    Kallel, H
    Ali, AB
    Dumay, MF
    Paoli, B
    Misset, B
    Carlet, J
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2001, 22 (11): : 687 - 692
  • [4] What Is the Significance of Staphylococcus aureus Colonization in Hemodialysis Patients?
    Krishna, Vinay Narasimha
    Allon, Michael
    NEPHRON, 2015, 129 (02) : 75 - 78
  • [5] Mortality and morbidity in hemodialysis arrhythmic and not arrhythmic patients
    Le, Bernardi
    Bonforte, G.
    Colantonio, G.
    Martinelli, D.
    Minoretti, C.
    Mangano, S.
    Padovese, P.
    Tettamanti, G.
    Melfa, G.
    D'Amico, M.
    Giura, C.
    Grillo, C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 334 - 334
  • [6] Effects of nutrition on morbidity and mortality in hemodialysis patients
    Acchiardo, SR
    Smith, SO
    DIALYSIS & TRANSPLANTATION, 2000, 29 (10) : 614 - +
  • [7] INFLUENCE OF GENETICS ON CARDIOVASCULAR MORBIDITY IN HEMODIALYSIS PATIENTS AND 7 YEARS FOLLOW UP MORTALITY
    Dragovic, Jelena Tosic
    Popovic, Jovan
    Djuric, Petar
    Jankovic, Aleksandar
    Bulatovic, Ana
    Dimkovic, Nada
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [8] INFLUENCE OF CO-MORBIDITY ON MORTALITY AND MORBIDITY IN PATIENTS TREATED WITH HEMODIALYSIS
    KEANE, WF
    COLLINS, AJ
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 24 (06) : 1010 - 1018
  • [9] ASSESSMENT OF THE RISK FOR CARDIOVASCULAR MORTALITY AND MORBIDITY IN HEMODIALYSIS PATIENTS
    Arsov, S.
    Graaff, R.
    Morariu, A. M.
    van Oeveren, W.
    Busletic, I.
    Trajcevska, L.
    Selim, G.
    Martinovska, A.
    Sikole, A.
    Ploeg, R. J.
    Rakhorst, G.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2008, 31 (07): : 592 - 592
  • [10] REDUCTION IN MORBIDITY AND MORTALITY AMONG HEMODIALYSIS-PATIENTS
    STRIKER, GE
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 21 (04) : 452 - 452